The 17 Sustainable Development Goals laid out in 2015 have been guiding lights for sustainable development over the last five years — and remain just as prevalent during our current global pandemic.
In partnership with the Zayed Sustainability Prize, this webinar will take a deep dive into the health sector and the power of partnerships to achieve progress. Featuring Dr. Christina Tewes-Gradl, Founder and Managing Director of Endeva and Senior Advisor at Business Fights Poverty, Katie Hyson, Director of Thought Leadership at Business Fights Poverty, Anneke Schmider, Associate Fellow, Global Health Programme at Chatham House and Anne Gadegaard, Associate Director, Senior Advisor, Global and Health Promotion at Novo Nordisk A/S.
The discussion will address:
- Innovative and promising shifts in the health sector
- The power of partnerships and collaboration in responding to the current global crisis and beyond
- What 2030 will look like and what it will take to achieve relevant SDGs.
This webinar will be facilitated by Carole Smets, Partner at ERM.
About the Zayed Sustainability Prize.
This series is in partnership with the Zayed Sustainability Prize. Established in 2008, this annual award recognises and rewards the achievements of those who are driving impactful, innovative and inspiring sustainability solutions across five distinct categories: Health, Food, Energy, Water and Global High Schools.
About Dr. Christina Tewes-Gradl
Dr. Christina Tewes-Gradl is an expert on inclusive business. As a founder and managing director of Endeva, she works with partners from all sectors to identify and implement innovative market-based solutions to poverty. Christina has more than 13 years of experience in research and advising on sustainability, strategy and development issues. She is a thought leader on inclusive business and related policies and ecosystems, having contributed more than 20 publications and speaking regularly at events on these topics.
Christina is a Research Fellow at the CSR Initiative of the Harvard Kennedy School, a Strategic Advisor to the UNDP Inclusive Market Initiative and a former Kofi Annan Fellow on Global Governance. She holds a PhD on the business model concept and Masters degrees from the University of Passau and LSE. Previously, Christina worked as a strategy consultant with McKinsey&Co and with rice farmers in Madagascar.
About Katie Hyson
Katie has over 10 years’ experience in business and social impact, including with multinationals in the finance and telecommunications sectors. Katie is an award-winning and published thought leader spanning disciplines of business innovation, stakeholder engagement and sustainability. As Director of Thought Leadership at Business Fights Poverty, Katie leads efforts to distil and distribute practical insights to enable businesses to scale their social impact. Previously, Katie worked for Barclays, where she led external stakeholder engagement and strategic relationships, as well as internal engagement and innovation for the bank on social and environmental agendas, and for Telefonica UK, where she developed an award winning sustainability internal engagement strategy. Katie holds an MA Environment Politics & Globalisation, King’s College London.
About Anneke Schmider
Anneke is a political economist who focuses on global health strategy, governance and innovation. Her portfolio of work includes research and policy projects for WHO, Canada IDRC, DFID, Australia’s DFAT, and the World Bank.
She has previously delivered award-winning initiatives to improve health and life sciences research and analysis at government level in Australia, and has advised on major investments in health and life sciences policy.
During her time at the World Health Organisation Anneke worked closely with countries in Africa and Asia, working closely with partners including Canada IDRC, UNICEF and the World Bank.
She holds graduate and postgraduate qualifications including an MSc focused on global health innovation, policy and financing; and postgraduate qualifications in health and life sciences innovation policy.
Her current PhD studies focus on innovation, evidence and partnerships for global health strategy and financing.
About Anne Gadegaard
Anne Gadegaard is Associate Director, Senior Advisor Corporate Sustainability in Novo Nordisk A/S, a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 42,600 people in 79 countries and markets its products in more than 170 countries.
Anne joined Novo Nordisk in 2000 working with data management of non-financials, assurance, CSR reporting and took part in the integration of Novo Nordisk’s financial and non-financial reporting into one integrated report in 2004. Anne was the Programme Director for Novo Nordisk’s Climate strategy and proved through the strategy the business case for integrating economic, social, and environmental considerations into decision making in the business. In 2013, Anne initiated the Environmental Profit & Loss Account work in Novo Nordisk, and is continuing the work in order to measure and account for Novo Nordisk’s full value.
Anne has represented Novo Nordisk in the Danish Mirror Committee for the ISO 26000 standard for Social Responsibility and industry at the international Working Group meetings from the first WG-meeting in Brazil till the last in Copenhagen in 2010. Anne has been Novo Nordisk’s UN Global Compact liaison and instrumental in Novo Nordisk engagement in the Post-2015 Development Agenda and the implementation of the Sustainable Development Goals in Novo Nordisk. Today, Anne is Associate Director, Senior Advisor for the framing of Novo Nordisk as a sustainable business.
With a Master of Science (MSc) in economics and organisation in production systems from Copenhagen business School, Anne worked for four years as a CSR-consultant in Deloitte for a number of big Danish companies and public authorities before joining Novo Nordisk.